Treatment of Young Adults with Acute Lymphoblastic Leukemia.

about

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

Item

http://www.wikidata.org/entity/Q39206217

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@en

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@nl

type

Item

label

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@en

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@nl

prefLabel

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@en

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@nl

P1476

Treatment of Young Adults with Acute Lymphoblastic Leukemia.

@en

P2093

Ankit Kansagra

http://www.w3.org/2001/XMLSchema#string

Mark Litzow

http://www.w3.org/2001/XMLSchema#string

P2860

L-asparaginase in the treatment of patients with acute lymphoblastic leukemia

Novel immunotherapies in lymphoid malignancies

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

How I treat acute lymphoblastic leukemia in older adolescents and young adults

Chimeric antigen receptor T cells for sustained remissions in leukemia

Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis.

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802.

P2888

s11899-017-0377-y

P304

187-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-017-0377-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28353017

http://www.w3.org/2001/XMLSchema#string